Raymond Vanholder
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Raymond Vanholder has a total of 633 co-authors. Here are the top co-authors by number of shared publications:
N Lameire
10 shared publicationsNorbert Lameire
8 shared publicationsGriet Glorieux
6 shared publicationsR De Smet
6 shared publicationsS Ringoir
6 shared publications- Annemieke Dhondt
Renal Division, Department of Medicine, University Hospital of Gent, Gent, Belgium
5 shared publications
Latest Publications
- Open Access
- 21 May 2015
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 30 (suppl_3) , iii142-iii143
FP227REDUCTION OF THE eGFR EXPRESSED AS PERCENTAGE CHANGE OF THE SLOPE PER YEAR MAY DISCRIMINATE CKD PATIENTS WITH FAST PROGRESSION
Introduction and Aims: Discovery of biomarkers as early predictors of the progression of chronic kidney disease (CKD) is the main focus of many studies today. In this context it is important to correctly define patients at risk for CKD progression. Since cohorts often lack long-term follow up and relatively few number of patients reach end points [end-stage renal disease (ESRD) or doubling of serum creatinine (SCr)] the definition of progressors might be uncertain. KDIGO guidelines for the evaluation and management of CKD suggest that -5ml decline/year may be considered as sign of fast progression. When the baseline estimated glomerular filtration rate (eGFR) is considered, even smaller decline may be associated with high percent change of the eGFR. Therefore, in cases with repeated measurements and wide variation in SCr levels and eGFR, linear regression for calculating the slope/year might be preferred. Thus, the percent change of the slope per year may be more appropriate indicator for CKD progression than percent change of the decline/year.
- 21 May 2015
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 30 (suppl_3) , iii142-iii143
Open AccessFP227REDUCTION OF THE eGFR EXPRESSED AS PERCENTAGE CHANGE OF THE SLOPE PER YEAR MAY DISCRIMINATE CKD PATIENTS WITH FAST PROGRESSION
Introduction and Aims: Discovery of biomarkers as early predictors of the progression of chronic kidney disease (CKD) is the main focus of many studies today. In this context it is important to correctly define patients at risk for CKD progression. Since cohorts often lack long-term follow up and relatively few number of patients reach end points [end-stage renal disease (ESRD) or doubling of serum creatinine (SCr)] the definition of progressors might be uncertain. KDIGO guidelines for the evaluation and management of CKD suggest that -5ml decline/year may be considered as sign of fast progression. When the baseline estimated glomerular filtration rate (eGFR) is considered, even smaller decline may be associated with high percent change of the eGFR. Therefore, in cases with repeated measurements and wide variation in SCr levels and eGFR, linear regression for calculating the slope/year might be preferred. Thus, the percent change of the slope per year may be more appropriate indicator for CKD progression than percent change of the decline/year.
- Open Access
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i472-i486
Epidemiology - CKD 5D II
Introduction and Aims: Adherence to treatment recommendations on diet, fluid and medication is important to maximize good clinical outcomes in Hemodialysis yet it remains suboptimal and not well-understood. This trial set out to examine the effect of the HED- SMART intervention, a four-session, group-delivered self-management intervention on treatment adherence indicators.
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i472-i486
Open AccessEpidemiology - CKD 5D II
Introduction and Aims: Adherence to treatment recommendations on diet, fluid and medication is important to maximize good clinical outcomes in Hemodialysis yet it remains suboptimal and not well-understood. This trial set out to examine the effect of the HED- SMART intervention, a four-session, group-delivered self-management intervention on treatment adherence indicators.
- Open Access
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i415-i427
Extracorporeal dialysis: techniques and adequacy II
Introduction and Aims: Hemodialysis (HD) patients are characterized by the presence of chronic inflammation, which contributes to the high morbidity and mortality of these patients. Recently, it was demonstrated that HD patients present increased levels of cell-free circulating DNA, probably due to the release of DNA from cellular necrosis and apoptosis. As cell–free DNA could lead to inflammation, and online-hemodiafiltration (OL-HDF) technique was proposed to associate a reduction in inflammation, we aimed to evaluate the effect of HD to OL-HDF change in cell-free circulating DNA serum levels.
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i415-i427
Open AccessExtracorporeal dialysis: techniques and adequacy II
Introduction and Aims: Hemodialysis (HD) patients are characterized by the presence of chronic inflammation, which contributes to the high morbidity and mortality of these patients. Recently, it was demonstrated that HD patients present increased levels of cell-free circulating DNA, probably due to the release of DNA from cellular necrosis and apoptosis. As cell–free DNA could lead to inflammation, and online-hemodiafiltration (OL-HDF) technique was proposed to associate a reduction in inflammation, we aimed to evaluate the effect of HD to OL-HDF change in cell-free circulating DNA serum levels.
- Open Access
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i30-i32
Extracorporeal techniques and adequacy
Introduction and Aims: Hemodiafiltration (HDF) is increasingly used as a means of improving the clearance of middle-weight molecular substances in patients with end stage renal disease. Post hoc analysis of two large randomized controlled trials showed that patients treated with the highest convective volume had a lower mortality risk. The aim of this study was to determine which factors influence the achieved convection volume in patients treated with post-dilution online (ol) HDF.
- 1 May 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (suppl 1) , i30-i32
Open AccessExtracorporeal techniques and adequacy
Introduction and Aims: Hemodiafiltration (HDF) is increasingly used as a means of improving the clearance of middle-weight molecular substances in patients with end stage renal disease. Post hoc analysis of two large randomized controlled trials showed that patients treated with the highest convective volume had a lower mortality risk. The aim of this study was to determine which factors influence the achieved convection volume in patients treated with post-dilution online (ol) HDF.
- 1 February 2008
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 63 (1) , 39-41
PULSATING TUMOUR IN THE CLAVICULAR REGION OF A CHRONIC HAEMODIALYSIS PATIENT WITH IPSILATERAL VASCULAR ACCESS CATHETER
We describe the case of a 70-year-old woman who presented with a pulsating mass in the left supraclavicular region during a haemodialysis session. The frequency of the pulsations, parallel to that of the dialysis-related blood flow cycle, without blood loss at the exit site, indicated that this observation could potentially be attributed to a rupture of the silastic material in the subcutaneous track of the catheter. Our hypothesis was confirmed after removal of the catheter.
- 1 February 2008
- Published by Taylor & Francis in Acta Clinica Belgica
- Vol. 63 (1) , 39-41
PULSATING TUMOUR IN THE CLAVICULAR REGION OF A CHRONIC HAEMODIALYSIS PATIENT WITH IPSILATERAL VASCULAR ACCESS CATHETER
We describe the case of a 70-year-old woman who presented with a pulsating mass in the left supraclavicular region during a haemodialysis session. The frequency of the pulsations, parallel to that of the dialysis-related blood flow cycle, without blood loss at the exit site, indicated that this observation could potentially be attributed to a rupture of the silastic material in the subcutaneous track of the catheter. Our hypothesis was confirmed after removal of the catheter.
- 12 January 2005
- Published by Wiley in Hemodialysis International
- Vol. 9 (1) , 80
Urea kinetics are not representative for the behavior of other small and water-soluble compounds
- 12 January 2005
- Published by Wiley in Hemodialysis International
- Vol. 9 (1) , 80
Urea kinetics are not representative for the behavior of other small and water-soluble compounds
- 1 October 2003
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 10 (4) , 257-269
Low water-soluble uremic toxins
- 1 October 2003
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 10 (4) , 257-269
Low water-soluble uremic toxins
- 1 May 2003
- Published by Elsevier in Kidney International
- Vol. 63 (84) , S6-S10
New insights in uremic toxins
- 1 May 2003
- Published by Elsevier in Kidney International
- Vol. 63 (84) , S6-S10
New insights in uremic toxins
- Top Cited Papers
- 1 May 2003
- Published by Elsevier in Kidney International
- Vol. 63 (5) , 1934-1943
Review on uremic toxins: Classification, concentration, and interindividual variability
- 1 May 2003
- Published by Elsevier in Kidney International
- Vol. 63 (5) , 1934-1943
Top Cited PapersReview on uremic toxins: Classification, concentration, and interindividual variability
- 1 April 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (2) , 162-167
Uremic Toxins: Removal with Different Therapies
A convenient way to classify uremic solutes is to subdivide them according to the physicochemical characteristics influencing their dialytic removal into small water‐soluble compounds (500 Da). The prototype of small water‐soluble solutes remains urea although the proof of its toxicity is scanty. Only a few other water‐soluble compounds exert toxicity (e.g., the guanidines, the purines), but most of these are characterized by an intra‐dialytic behavior, which is different from that of urea. In addition, the protein‐bound compounds and the middle molecules behave in a different way from urea, due to their protein binding and their molecular weights, respectively. Because of these specific removal patterns, it is suggested that new approaches of influencing uremic solute concentration should be explored, such as specific adsorptive systems, alternative dialytic timeframes, removal by intestinal adsorption, modification of toxin, or general metabolism by drug administration. Middle molecule removal has been improved by the introduction of large pore, high‐flux membranes, but this approach seems to have come close to its maximal removal capacity, whereas multicompartmental behavior might become an additional factor hampering attempts to decrease toxin concentration. Hence, further enhancement of uremic toxin removal should be pursued by the introduction of alternative concepts of elimination.
- 1 April 2003
- Published by Wiley in Hemodialysis International
- Vol. 7 (2) , 162-167
Uremic Toxins: Removal with Different Therapies
A convenient way to classify uremic solutes is to subdivide them according to the physicochemical characteristics influencing their dialytic removal into small water‐soluble compounds (500 Da). The prototype of small water‐soluble solutes remains urea although the proof of its toxicity is scanty. Only a few other water‐soluble compounds exert toxicity (e.g., the guanidines, the purines), but most of these are characterized by an intra‐dialytic behavior, which is different from that of urea. In addition, the protein‐bound compounds and the middle molecules behave in a different way from urea, due to their protein binding and their molecular weights, respectively. Because of these specific removal patterns, it is suggested that new approaches of influencing uremic solute concentration should be explored, such as specific adsorptive systems, alternative dialytic timeframes, removal by intestinal adsorption, modification of toxin, or general metabolism by drug administration. Middle molecule removal has been improved by the introduction of large pore, high‐flux membranes, but this approach seems to have come close to its maximal removal capacity, whereas multicompartmental behavior might become an additional factor hampering attempts to decrease toxin concentration. Hence, further enhancement of uremic toxin removal should be pursued by the introduction of alternative concepts of elimination.